检索

Targetnaya terapiya raka pochki

Alekseev B., Shegay P.

Lekarstvennaya terapiya solidnykh opukholey s metastazami v golovnom mozge

Konstantinova M.

The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor

Molekulyarno-biologicheskie faktory prognoza pri B-kletochnom khronicheskom limfoleykoze

Nikitin E., Malakho S., Biderman B., Poltaraus A., Sudarikov A.

卷 26, 编号 4 (2024)

The role of ESR1 gene mutation in therapy selection for HR+/HER2- metastatic breast cancer: A review

Paichadze A., Chashnikova E., Golubeva S.

(Rus)

卷 25, 编号 4 (2023)

Hyperbaric oxygen therapy for the treatment of the late effects of radiotherapy [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]

Yudina E.

(Rus)

卷 24, 编号 2 (2022)

Cabozantinib in the treatment of patients with advanced renal cell carcinoma

Volkova M., Turupaev K., Kalinin S.

(Rus)

卷 23, 编号 4 (2021)

The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021

Editorial B.

(Rus)

卷 23, 编号 3 (2021)

Malignant neoplasms associated with HIV infection. Problems and solutions (problem outline)

Kaprin A., Voronin E., Rassokhin V., Rozenberg V., Nekrasova A., Falaleeva N., Ivanov S., Grivtsova L.

(Rus)

卷 23, 编号 1 (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype

Ganshina I., Ivanova K., Gordeeva O., Arkhipov A., Zhukova L.

(Rus)

卷 21, 编号 4 (2019)

The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution

Poddubnaya I., Bialik T., Glonina N., Kalashnikova O., Kaplanov K., Lapin V., Medvedeva N., Mikhailova N., Moiseeva T., Nikitin E., Pospelova T., Stadnik E.

(Rus)

卷 20, 编号 2 (2018)

The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan

Berdimyradova M., Khadjiev S., Khommadova D., Polatova G., Kakajanova A., Batyrov C., Penayev D., Agayeva B., Annaberdiyeva G.

(Rus)

卷 19, 编号 1 (2017)

Ryazhenov V.

(Rus)

卷 18, 编号 1 (2016)

Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib

Sheko S., Dem'yanova G.

(Rus)

卷 17, 编号 1 (2015)

The role of targeted therapy in the treatment of advanced hepatocellular carcinoma

Shakhnovich E., Kerbikov O., Kulaga E.

卷 16, 编号 3 (2014)

Modern options in personalized therapy of metastatic cutaneous melanoma

Protsenko S., Novik A., Akhaeva Z., Zhabina A., Imyanitov E., Semenova A.

Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives

Alekseev B., Nyushko K., Kalpinskiy A., Kaprin A.

卷 15, 编号 3 (2013)

Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka

Timofeev I.

卷 15, 编号 1 (2013)

Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results

Garbuzov M.

卷 11, 编号 4 (2009)

Ad\"yuvantnaya terapiyav lechenii gastrointestinal'nykh stromal'nykh opukholey

Nikulin M., Stilidi I.

Ingibitory vnutrikletochnoy peredachi signala pri melanome: perspektivy i razocharovaniya targetnoy terapii

Konstantinova M.

Znachenie luchevoy terapii v lechenii generalizovannykh nekhodzhkinskikh limfom (IV stadiya)

Kharchenko V., Pan'shin G., Sotnikov V., Datsenko P., Smol'tsova N., Nikolaeva E.

Nekhodzhkinskie limfomy mochepolovoy sistemy

Bogdanov A., Maksimov A., Anosov N., Krivolapov Y.

卷 7, 编号 1 (2005)

Opyt primeneniya Regional'noy programmy v g. Krasnodare

Mitashok I.

卷 26, 编号 3 (2024)

New therapies for hormone-positive HER2-negative metastatic breast cancer with AKT signaling alterations: the Expert Panel Decision

Editorial B.

(Rus)

卷 25, 编号 4 (2023)

How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review

Zhukova L., Bordin D., Dubtsova E., Ilin M., Kiriukova M., Feoktistova P., Egorov V.

(Rus)

卷 25, 编号 1 (2023)

Can musical interventions benefit patients with cancer?

Razumovskaya E.

(Rus)

卷 24, 编号 2 (2022)

The effect of antioxidant drugs on the self-assessment of clinical symptoms in women during radiation therapy after surgical treatment of endometrial cancer: Placebo-controlled randomized trial

Volchegorskii I., Vazhenin A., Alekseeva A.

(Rus)

卷 23, 编号 2 (2021)

Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report

Protasova A., Strakh L., Lando E., Sidorkina E.

(Rus)

卷 23, 编号 1 (2021)

Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)

Ziganshin A.

(Rus)

卷 22, 编号 3 (2020)

Prospects for the development of adjuvant therapy for non-small cell lung cancer

Laktionov K., Kazakov A., Reutova E., Ardzinba M., Arzumanian A.

(Rus)

卷 21, 编号 4 (2019)

Modern immunological criteria for a stratification of risk groups for precursor B cell acute lymphoblastic leukemia in children

Shervashidze M., Valiev T., Batmanova N., Tupitsyn N., Serebryakova I.

(Rus)

卷 20, 编号 1 (2018)

Dermatomyositis and polymyositis in breast cancer patients: a case reports

Ganshina I., Zhukova L., Burnevitch E., Gordeeva O., Kondratieva O.

(Rus)

卷 19, 编号 1 (2017)

Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer

Pavlikova O., Kolyadina I., Komov D., Vishnevskaya Y., Poddubnaya I.

(Rus)

卷 18, 编号 1 (2016)

The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options

Artamonova E., Manzyuk L.

(Rus)

卷 17, 编号 1 (2015)

Radiation-induced lung injury in breast cancer patients after breast conservation therapy

Trofimova O., Tkachev S., Ivanov S., Utkina V., Cheban O., Glebovskaya V.

Angiogenesis as a target for cancer therapy

Imyanitov E.

卷 15, 编号 4 (2013)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)

Semiglazov V., Semiglazov V., Paltuev P., Nikolaev K., Dashyan G.

卷 15, 编号 1 (2013)

Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies

Kit O., Vladimirova L., Sholokhova E.

卷 11, 编号 4 (2009)

Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade

Lichinitser M., Semenov N.

卷 10, 编号 1 (2008)

Novye vozmozhnosti targetnoy terapii neyropaticheskoy boli v onkologii

Abuzarova G., Prokhorov B., Sokolenov A., Shakhnovich E.

Sutent® (Sutent, SU11248) – novyy mul'titargetnyy ingibitor angiogeneza opukholey

Imyanitov E.

Rol' luchevoy terapii v lechenii bol'nykh ekstranodal'nymi zlokachestvennymi limfomami

Il'in N., Vinogradova Y., Nikolaeva E., Ivanova E.

Limfoma iz kletok mantiynoy zony: klinicheskie osobennosti i vozmozhnosti terapii

Lorie Y.

卷 7, 编号 1 (2005)

Analiz rezul'tatov vnedreniya Regional'noy rossiyskoy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy v Voronezhskom oblastnom klinicheskom onkologicheskom dispansere

Chevardov N., Tolstykh L., Puzakov K., Potapov Y.

卷 25, 编号 3 (2023)

Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]

Melnikov V.

(Rus)

卷 24, 编号 2 (2022)

Modern strategy of treatment of patients with retroperitoneal sarcomas: A review

Stilidi I., Nikulin M., Kalinin O., Abgiarian M., Vashakmadze L., Fainshtein I., Arkhiri P., Salimova A.

(Rus)

卷 23, 编号 4 (2021)

The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem The results of the project with the discussion concerning the possibility of optimization approaches for the therapy

Editorial B.

(Rus)

卷 23, 编号 2 (2021)

Erythropoietin or darbepoetin for patients with cancer (Russian Translation of Cochrane Plain Language Summary – PLS)

Lienhard D.

(Rus)

卷 22, 编号 4 (2020)

Vulvar cancer: brain metastases. Clinical observation

Ognerubov N., Antipova T., Kamneva N.

(Rus)

卷 21, 编号 3 (2019)

Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer

Musaeva Z., Chekalova M., Mesheryakov A.

(Rus)

卷 19, 编号 4 (2017)

Clinical cases of the treatment of metastatic colorectal cancer in Russia

Goldberg V., Hasanova A., Shkuratova V., Belevich Y., Popova N., Simolina E., Vysockaya V., Dudnikova E., Kravchuk T., Minnabetdinova R., Nekrasova O.

(Rus)

卷 17, 编号 3 (2015)

Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer

Knyazev R., Poddubnaya I., Barinov V., Bokin I.

卷 16, 编号 3 (2014)

Vulvar Langerhans cell histiocytosis: case report

Poddubnaya I., Razumova E., Kizhaev Y., Ukolova E., Teterin K.

Modern technology of radiation therapy: IMRT, VMAT using simultanting integrated boost (SIB) in the complex treatment of squamous cell carcinoma of the anal canal

Tkachev S., Glebovskaya V., Rasulov A., Tsariuk V., Aliev V., Vodyanik V.

卷 16, 编号 1 (2014)

The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program

Poddubnaya I., Bichurina S., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Petrukhnenko V., Sivunova I., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.

卷 15, 编号 3 (2013)

Prognosticheskoe znachenie lokal'nogo i sistemnogo lecheniya pri rake molochnoy zhelezy I stadii

Kolyadina I., Poddubnaya I., Trofimova O., Komov D., Karseladze A., Ermilova V., Vishnevskaya Y., Frank G., Banov S.

卷 11, 编号 3 (2009)

Rol' pemetrekseda (Alimta) v lechenii rasprostranennogo neploskokletochnogonemelkokletochnogo raka legkogo

Poddubnaya I.

卷 10, 编号 1 (2008)

Ad\"yuvantnoe lechenie raka tolstoy kishki

Artamonova E., Podregul'skiy K.

Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie

Komarova V., Komarova L., Poddubnaya I.

Is maintenance therapy following previous treatment better than observation or placebo for treating chronic lymphocytic leukaemia in adults? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)

Osobennosti klinicheskogo techeniya i prognoz bol'nykh nekhodzhkinskoy limfomoy s pervichnoy lokalizatsiey v yaichke

Tumyan G., Kovrigina A., Timofeeva O., Probatova N., Sholokhova E., Tupitsyn N., Poddubnaya I., Osmanov D.

卷 7, 编号 3 (2005)

Sovremennye vozmozhnosti lekarstvennoy terapii operabel'nogo raka molochnoy zhelezy (po materialam St. Gallen, 2005)

Letyagin V., Vysotskaya I.

卷 26, 编号 2 (2024)

Editorial B.

(Rus)

卷 25, 编号 3 (2023)

International experience by using of the SJMB protocols in treatment of children with medulloblastoma in the age group over 3 years (literature review)

Levashov A., Zagidullina S., Valiev T., Stroganova A., Khochenkov D., Grigorenko V., Mikhaylova E., Tyurina E., Ryzhova M., Horielyshev S., Kadyrov S., Polyakov V.

(Rus)

卷 25, 编号 1 (2023)

Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review

Kolyadina I.

(Rus)

卷 25, 编号 2 (2023)

Radiation induced skin reactions in primary cutaneous lymphoma patients: A review

Ilyin N., Vinogradova Y., Zaslavskiy D., Maria M.

(Rus)

卷 23, 编号 4 (2021)

Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON

Tryakin A., Fedyanin M., Moiseenko F., Mironov O., Stroyakovskiy D., Sokolov N., Orlova S., Mantsyrev E., Sultanbaev A., Teterich A., Babina K., Yukalchuk D., Borzyanitsa S., Isyangulova A., Saidullaeva A., Chernova Y., Bobrova E., Fadeeva N., Chobanu D.

(Rus)

卷 23, 编号 2 (2021)

Anti-anemia drugs shorten survival for some cancer patients (Russian Translation of Cochrane Plain Language Summary – PLS)

Ziganshin A.

(Rus)

卷 22, 编号 4 (2020)

The role of radiation therapy in the treatment of patients with pleural mesothelioma

Borisova T., Tkachev S., Ivanov S., Alieva S., Trofimova O., Glebovskaya V., Breder V., Laktionov K., Marinov D., Abdullaev A.

(Rus)

卷 23, 编号 1 (2021)

Opportunities for metastatic triple negative breast cancer therapy

Ganshina I., Gordeeva O., Manukyan M.

(Rus)

卷 21, 编号 2 (2019)

Effective use of the endoscopic vacuum system in the comprehensive treatment of a patient with a defect in the abdominal segment of the esophagus after gastrectomy

Abu-Khaidar O., Vodoleev A., Pirogov S., Khomiakov V., Riabov A.

(Rus)

卷 19, 编号 2 (2017)

Targeted therapy in pediatric malignancies treatment: Pediatric Oncology and Haematology Research Institute experience

Valiev T., Levashov A., Batmanova N., Senzhapova E., Turupaev K., Tomchik U., Aleskerova G.

(Rus)

卷 18, 编号 4 (2016)

Molecular genetic features of the head and neck (upper aerodigestive tract) mucosal melanoma

Ignatova A.

卷 17, 编号 3 (2015)

Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer

Bazaeva I., Gorbounova V., Kravets O., Khokhlova S., Romanova E.

卷 17, 编号 1 (2015)

Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer

Semiglazova T., Dashyan G., Semiglazov V., Zhabina A., Osipov M., Kotova Z., Klimenko V., Krivorotko P., Semiglazov V.

卷 16, 编号 1 (2014)

Radiation therapy as an independent method of treatment in case of carcinoma of floor of mouth

Garbuzov M.

New horizons in skin malignancies treatment

Gamaunov S.

卷 15, 编号 3 (2013)

Targetnaya terapiya metastaticheskogo raka zheludka: klinicheskiy opyt uspeshnogo lecheniya patsienta s retsidivom raka zheludka

Tlish E.

卷 11, 编号 3 (2009)

Otdalennye rezul'taty khirurgicheskogo lecheniya gastrointestinal'nykh stromal'nykh opukholey zheludochno-kishechnogo trakta

Istomin Y., Evdokimov M.

卷 9, 编号 4 (2007)

Erbituks – ratsional'no sozdannyy preparat dlya lecheniya zlokachestvennykh opukholey

Garin A., Bazin I., Nasyrova R.

卷 9, 编号 2 (2007)

Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii

Zavalishina L., Andreeva Y., Ryazantseva A., Bateva M., Frank G.